Call us today: +1 (304) 470-2225
You can use WPML or Polylang and their language switchers in this area.

Bespoke Tumour & Rare Disease Decks

Bespoke Decks in Oncology, Rare Disease, Neurology & others

Mellalta Bespoke Tumor and Rare Disease Decks

Dive into the future of disease portfolio strategy with The Bespoke Disease Deck – your ultimate tool for mastering the market! Think of it as your crystal ball for cancer, rare diseases, and neurology markets.

The Bespoke Disease Deck is a tool for Pharma & biopharma companies to help them better understand and strategize their disease portfolios. The deck provides a complete view of the market and competitors’ assets in cancer, rare diseases and neurology, as well as the competitive landscape over the next 10 years. With our deck, you can identify trends and opportunities, and then strategize around them in order to position your company for success.

Identifying Opportunities

  • Comprehensive Market Overview: Gain a 360-degree view of the cancer, rare disease, and neurology markets.
  • Decade-Long Forecast: Anticipate market shifts and trends for the next 10 years.
  • Competitive Intelligence: Understand your competitors’ strategies and assets in depth.
  • Opportunity Identification: Spot emerging opportunities before they become mainstream.
  • Strategic Positioning: Use insights to strategically position your company for long-term success.
  • Informed Decision Making: Make decisions backed by data-driven insights and analysis.
  • Risk Mitigation: Stay ahead of potential market risks and challenges.
  • Innovation Catalyst: Identify gaps and areas for innovation in your portfolio.
  • Trend Analysis: Keep your finger on the pulse of industry changes and advancements.
  • Future-Proofing Strategies: Equip your company with knowledge to thrive in a rapidly evolving industry.

The future of medicine is a lot more complicated than we think. The world is going to get more crowded and competitive, with new drugs and therapies coming on the market every year. And that means it’s time for you to start thinking about the disease deck.

We know how hard it can be to keep track of all those new developments—and even more important, we know that you want to make sure your company stays ahead of the curve. That’s why we’ve made it our mission to help you do just that: identify the assets and opportunities that are going to be important in your industry over the next 10 years.

We also have some great KOLs who can help guide you through the process of identifying where your company fits into this already-crowded landscape—and what it means for your future.

In an industry that never sleeps, being unprepared isn’t just a misstep; it’s a risk you can’t afford. The market is evolving rapidly, and those who don’t adapt are left behind. Without the deep market understanding that The Bespoke Disease Deck offers, you might miss emerging trends, overlook key competitor moves, and find your strategies outdated in the face of tomorrow’s challenges. Don’t let your company be outpaced by competitors who embrace foresight and preparation.

The future is now. The Bespoke Disease Deck is your key to unlocking it. Seize this opportunity to lead your company with confidence, backed by knowledge and strategy.

Our Deck includes

-Disease background: a thorough overview of the disease, including its history and current market trends.

-Competitive Landscape: an analysis of the competitors in your industry, their products and services, and their market share. This allows you to see where your company stands in relation to its competition.

-Market Forecast Trends: analysis of how the market is going to look like in next 10 years with insights for what assets/MOAs/modalities will be valuable.

-KOLs inputs for the interesting Assets/MOAs/modalities: input from our industry experts about what kind of assets could help address these opportunities.

Identifying Opportunities: identifying opportunities where new technology could be applied – for example, pharmaceutical companies should consider using artificial intelligence as a way to improve drug discovery.

We’ve worked with some of the biggest pharmaceutical companies in the world on their asset creation process.

We’ve also worked with some of the most promising start-ups on their development processes.

This deck gives you all of our knowledge distilled into one easy-to-use package!

Case Studies